Page 105 - Heca News Today

A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease, a "stunning" result that potentially adds another weapon to combat the pandemic.

U.S. Secretary of State Antony Blinken on Friday named two new officials to coordinate Washington's response to so-called Havana Syndrome health incidents that have affected U.S. diplomats and officials overseas.

Merck has signed eight deals to sell more than a total of 2 million courses of its experimental COVID-19 pill molnupiravir to governments around the world as countries scramble to tame the virus.

Italy's medicines agency AIFA on Wednesday recommended a booster of the Pfizer -BioNTech or Moderna vaccine to those innoculated with the Johnson & Johnson shot.

Belgium on Thursday reported a steep rise in COVID-19 infections and hospitalisations back to levels last experienced in October 2020, three days after the United States advised its citizens against travelling to the country that hosts EU and NATO headquarters.

The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that have yet to be certified by peer review.

Germany's pandemic-related state of emergency looks set to expire next month after the three political parties in talks to form the next government said on Wednesday they did not support extending it.

Police in Vietnam have prosecuted a deputy health minister over his alleged involvement in a fake medicine trading ring, the country's security agency said on Thursday.

A look at the day ahead from Danilo Masoni.

A new U.S. workplace rule that requires tens of millions of Americans to get vaccinated for COVID-19 or submit to weekly testing will exclude employees who work exclusively outdoors, according to regulatory filing by the Occupational Safety and Health Administration.